Results from this preliminary study suggest that further studies should be implemented to investigate the efficacy of a combination of anti-CADM1 antibodies and chemotherapy drugs in the treatment of ATLL. The gene discussed is CADM1; the disease is adult T-cell leukemia/lymphoma.